Rare diseases have kept their secrets long enough
Go beyond standard testing to uncover the mechanisms behind hard-to-diagnose conditions. With flexible, end to end workflows and real-time data, Oxford Nanopore sequencing empowers you to resolve the full spectrum of variants and methylation in one go – and bring answers to those who need them most.
Why choose Oxford Nanopore?
The most complete view of genomic variants and epigenetic modifications.
Sample-to-answer whole genome sequencing in just 24 hours.
A single, unified platform to replace multiple assays.
Compatibility with tertiary analysis and interpretation partners
The value that you get with a technology such as long-read sequencing really surpasses and is much more important and easier to analyse than any other data type out there.Danny Miller
University of Washington
PromethION 24
Combining up to 24 independently addressable, high-capacity flow cells with powerful, integrated compute, PromethION 24 delivers flexible, on-demand access to terabases of ultra-rich sequencing data — ideal for comprehensive variant identification across large numbers of clinical research samples.
New approaches for human and clinical research
In this white paper, we explore how Oxford Nanopore sequencing of native DNA and RNA overcome the limitations of short-read sequencing to deliver the most comprehensive characterisation of the human genome.
